Sign up for free insights newsletter
60

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

600332SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥25.12
-1.34%
End of day
Market Cap

$41.28B

P/E Ratio

13.80

Employees

28,138

Dividend Yield

3.15%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.21-0.57-0.41
Calmar-0.19-0.61-0.42
Sharpe-0.15-0.45-0.32
Omega0.980.920.95
Martin-0.30-1.12-0.75
Ulcer5.615.255.41

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) Price Performance

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at CNY25.12, down 1.34% from the previous close.

Over the past year, 600332 has traded between a low of CNY24.92 and a high of CNY27.59. The stock has lost 6.5% over this period. It is currently 9.0% below its 52-week high.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has a market capitalization of $41.28B, with a price-to-earnings ratio of 13.80 and a dividend yield of 3.15%.

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical apparatus, and healthcare products; research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health preservation and elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy outlets and retail stores. The company operates in the People's Republic of China and internationally. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$77.54B
EBITDA
$4.25B
Profit Margin
3.85%
EPS (TTM)
1.84
Book Value
23.32

Technical Indicators

52 Week High
CN¥27.85
52 Week Low
CN¥24.56
50 Day MA
CN¥25.27
200 Day MA
CN¥26.01
Beta
0.29

Valuation

Trailing P/E
13.80
Forward P/E
52.91
Price/Sales
0.53
Price/Book
1.09
Enterprise Value
$41.82B